VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 560 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2015. The put-call ratio across all filers is 2.18 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $220,000 | -71.9% | 13,798 | +214.2% | 0.57% | +117.6% |
| Q3 2015 | $784,000 | +165.8% | 4,392 | +231.2% | 0.26% | +133.9% |
| Q2 2015 | $295,000 | -52.2% | 1,326 | -57.3% | 0.11% | -65.9% |
| Q1 2015 | $617,000 | +124.4% | 3,106 | +47.9% | 0.33% | +412.5% |
| Q3 2014 | $275,000 | -60.3% | 2,100 | -60.0% | 0.06% | -58.7% |
| Q1 2014 | $692,000 | +94.9% | 5,254 | +54.5% | 0.16% | -27.9% |
| Q3 2013 | $355,000 | – | 3,400 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |